City

Amsterdam (1)

Chandler (1)

Chapel Hill (1)

Dallas (1)

Dayton (1)

Frankfurt am main (1)

Houston (1)

Jena (1)

Condition

Fetal and Neonatal Alloimmune Thrombocytopenia (3)

Overall Status

Completed (2)

Recruiting (1)

Phase

n/a (1)

Sponsor

Leiden University Medical Center (1)

Prophylix Pharma AS (1)

Rallybio IPA, LLC (1)

Collaborator

Bioscientia Central Laboratory (1)

Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen (1)

Fraunhofer Institute for Molecular Biology and Applied Ecology (1)

Landsteiner Foundation for Blood Transfusion (1)

Larix A/S (1)

Sanquin Research & Blood Bank Divisions (1)

Intervention

clinical data collection (1)

clinical data collection. (1)

platelet transfusion (1)

Study Documents

Approval Medical Ethical Committee (1)

Information website (1)

Informed Consent Form (1)

Study Protocol (1)

Intervention Type

other (3)

Funder Type

Industry (2)

Other (1)

Study Type

Observational (2)

Interventional (1)

fetal and neonatal alloimmune thrombocytopenia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Assess Occurrence of HPA-1a Alloimmunization in Higher Risk for

Recruiting

Fetal and Neonatal Alloimmune Thrombocytopenia

Clinical data collection

Chandler, Arizona
+5 more

Apr 19, 2022

Towards Routine HPA-screening In Pregnancy to Prevent FNAIT

Completed

Fetal and Neonatal Alloimmune Thrombocytopenia

Clinical data collection.

Amsterdam, Netherlands

Stichting Bloedbank Sanquin

Sep 1, 2020

Fetal and Neonatal Alloimmune Thrombocytopenia Trial in Frankfurt am main (Platelet transfusion)

Completed

Fetal and Neonatal Alloimmune Thrombocytopenia

Platelet transfusion

Frankfurt am main, Hessia, Germany

Fraunhofer Institute for Molecular Biology and Applied Ecology I

May 9, 2019